Tag: innovation
Sartar was chosen among the top 30 innovative life science companies in RESI Innovation Challenge
10.3.2020
We are honored to be selected as one of the most innovative companies in RESI Europe 2020 Innovation Challenge in the therapeutics category. Link to original news
Sartar was granted a Japan patent
25.1.2019
Sartar was awarded a patent in Japan for the use of anagrelide in cancer therapy.
Pekka Simula joins Sartar’s board of directors
26.9.2018
Sartar strengthens the board of directors. CEO of Herantis Pharma, Pekka Simula, has been appointed as a new member to the Sartar Therapeutics board of directors.
Sartar was awarded a U.S. patent
16.10.2017
Sartar was awarded a U.S. patent for use of anagrelide in cancer therapy.